Evaluation of subretinally delivered Cas9 ribonucleoproteins in murine and porcine animal models highlights key considerations for therapeutic translation of genetic medicines
Spencer C. Wei(The University of Texas MD Anderson Cancer Center), Adam P. Silverman(Northwell Health)
Cited by 2
Related Papers
Combination anti–CTLA-4 plus anti–PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies
|Proceedings of the National Academy of Sciences|2019|357
Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation
|Journal of Clinical Investigation|2018|186